Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Oak Ridge, TN
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative site
mi
from
Dallas, TX
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Livingston, TX
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Livingston, TX
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Tacoma, WA
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Marion, OH
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Marion, OH
Click here to add this to my saved trials
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated:  9/16/2015
Novartis Investigative Site
mi
from
Gabrovo,
Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients
A Multicenter, Randomized, Double-blind, Parallel Group Study to Assess the Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients Comparing Two Titration Regimens
Status: Enrolling
Updated: 9/16/2015
Novartis Investigative Site
mi
from
Gabrovo,
Click here to add this to my saved trials
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Evaluation of Genetic Variants in Patients With Type 1 Neovascularization (Sub-retinal Pigment Epithelium Neovascularization) Who Lack Typical Findings of Age Related Macular Degeneration (AMD) But Present With Findings More Consistent With Long-standing Central Serous Chorioretinopathy (CSC).
Status: Enrolling
Updated:  9/17/2015
Vitreous Retina Macula Consultants of New York, P.C.
mi
from
New York City, NY
Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD
Evaluation of Genetic Variants in Patients With Type 1 Neovascularization (Sub-retinal Pigment Epithelium Neovascularization) Who Lack Typical Findings of Age Related Macular Degeneration (AMD) But Present With Findings More Consistent With Long-standing Central Serous Chorioretinopathy (CSC).
Status: Enrolling
Updated: 9/17/2015
Vitreous Retina Macula Consultants of New York, P.C.
mi
from
New York City, NY
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Thomas Hospital
mi
from
Fairhope, AL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Thomas Hospital
mi
from
Fairhope, AL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Mercy Gilbert Medical Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Heart & Vascular Center of Arizona
mi
from
Phoenix, AZ
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Heart & Vascular Center of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Scottsdale Health Care
mi
from
Scottsdale, AZ
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Scottsdale Health Care
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Arkansas Heart Hospital
mi
from
Little Rock, AR
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Arkansas Heart Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
California Cardiovascular Consultants/ Washington Hospital
mi
from
Fremont, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
California Cardiovascular Consultants/ Washington Hospital
mi
from
Fremont, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Foundation for Cardiovascular Medicine
mi
from
La Jolla, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Foundation for Cardiovascular Medicine
mi
from
La Jolla, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Mercy General Hospital
mi
from
Sacramento, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Mercy General Hospital
mi
from
Sacramento, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
UC San Diego Medical Center
mi
from
San Diego, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
UC San Diego Medical Center
mi
from
San Diego, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
California Pacific Medical Center
mi
from
San Francisco, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Joseph's Medical Center- CA
mi
from
Stockton, CA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Joseph's Medical Center- CA
mi
from
Stockton, CA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Medical Center of Aurora
mi
from
Aurora, CO
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Medical Center of Aurora
mi
from
Aurora, CO
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Bridgeport Hospital
mi
from
Bridgeport, CT
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Bridgeport Hospital
mi
from
Bridgeport, CT
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Connecticut Clinical Research, LLC
mi
from
Bridgeport, CT
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Connecticut Clinical Research, LLC
mi
from
Bridgeport, CT
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Bay Area Cardiology Associates/ Brandon Regional Hospital
mi
from
Brandon, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Bay Area Cardiology Associates/ Brandon Regional Hospital
mi
from
Brandon, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Jacksonville Heart Center
mi
from
Jacksonville, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Jacksonville Heart Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Diagnostic Cardiology Associates
mi
from
Lauderdale Lakes, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Diagnostic Cardiology Associates
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Munroe Regional Medical Center
mi
from
Ocala, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Munroe Regional Medical Center
mi
from
Ocala, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Ocala Regional Medical Center
mi
from
Ocala, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Ocala Regional Medical Center
mi
from
Ocala, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Florida Hospital
mi
from
Orlando, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Sacred Heart Hospital
mi
from
Pensacola, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Sacred Heart Hospital
mi
from
Pensacola, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Baptist Hospital
mi
from
Pensacola, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Baptist Hospital
mi
from
Pensacola, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Pepin Heart Hospital
mi
from
Tampa, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Pepin Heart Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Winter Haven Hospital
mi
from
Winter Haven, FL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Winter Haven Hospital
mi
from
Winter Haven, FL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Emory University Hospital Midtown
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Redmond Regional Hospital
mi
from
Rome, GA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Redmond Regional Hospital
mi
from
Rome, GA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Advocate Good Shephard Hospital
mi
from
Barrington, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Advocate Good Shephard Hospital
mi
from
Barrington, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Rush University Medical Center
mi
from
Chicago, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Jesse Brown VA Medical Center
mi
from
Chicago, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Jesse Brown VA Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Elmhurst Memorial Hospital
mi
from
Elmhurst, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Elmhurst Memorial Hospital
mi
from
Elmhurst, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Heartland Education and Research Foundation
mi
from
Joliet, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Heartland Education and Research Foundation
mi
from
Joliet, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Heart Care Research Foundation
mi
from
Mokena, IL
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Heart Care Research Foundation
mi
from
Mokena, IL
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Midwest Cardiovascular Research and Education Foundation
mi
from
Elkhart, IN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Midwest Cardiovascular Research and Education Foundation
mi
from
Elkhart, IN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Vincent Hospital/ Providence Heart Hospital
mi
from
Portland, OR
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Vincent Hospital/ Providence Heart Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Northwest Indiana Cardiovascular Physicians, P.C.
mi
from
Valparaiso, IN
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Northwest Indiana Cardiovascular Physicians, P.C.
mi
from
Valparaiso, IN
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
McFarland Clinic, PC
mi
from
Ames, IA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
St. Luke's Hospital - Cedar Rapids
mi
from
Cedar Rapids, IA
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
St. Luke's Hospital - Cedar Rapids
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated:  9/18/2015
Kings Daughters Medical Center
mi
from
Ashland, KY
The Dual Antiplatelet Therapy Study (DAPT Study)
A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions
Status: Enrolling
Updated: 9/18/2015
Kings Daughters Medical Center
mi
from
Ashland, KY
Click here to add this to my saved trials